Sponsor Pipeline

L & L Bio Co., Ltd., Ningbo, China Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
1
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 2/3
1
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT07177716 Efficacy and Safety of LB1410 Plus Lenvatinib With or Without LB4330 in Advanced… Cervical Cancer Not Yet Recruiting
Phase 1/2
NCT06468358 A Study to Evaluate LB1410 in Combination With LB4330 in Patients With Advanced or… Solid Tumor Recruiting
Phase 1
NCT05357651 A Study to Assess the Safety and Efficacy of LB1410 in Participants With Advanced Solid… Solid Tumor Recruiting
Disease Areas
Cervical Cancer (1)
Get alerts when L & L Bio Co., Ltd., Ningbo, China's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free